[{"address1": "900 North Point Parkway", "address2": "Suite 200", "city": "Alpharetta", "state": "GA", "zip": "30005", "country": "United States", "phone": "678 270 3631", "fax": "678 270 4033", "website": "https://clearsidebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.", "fullTimeEmployees": 30, "companyOfficers": [{"maxAge": 1, "name": "Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.", "age": 72, "title": "President, CEO & Director", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 836154, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles A. Deignan", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 568676, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jenny R. Kobin", "age": 57, "title": "Head of Investor Relations", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rick  McElheny", "title": "Senior Vice President of Corporate Development & Alliance Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rafael V. Andino", "age": 59, "title": "Senior Vice President of Engineering & Manufacturing", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Susan L. Coultas Ph.D.", "title": "Chief Clinical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ngai Hang  Chong FRCOphth, FRCS, M.B.A., M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leslie B. Zacks J.D.", "age": 55, "title": "Secretary", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.97, "open": 0.97, "dayLow": 0.9655, "dayHigh": 1.045, "regularMarketPreviousClose": 0.97, "regularMarketOpen": 0.97, "regularMarketDayLow": 0.9655, "regularMarketDayHigh": 1.045, "payoutRatio": 0.0, "beta": 2.104, "forwardPE": -2.0198, "volume": 296033, "regularMarketVolume": 296033, "averageVolume": 239744, "averageVolume10days": 214750, "averageDailyVolume10Day": 214750, "bid": 0.9913, "ask": 1.01, "bidSize": 1, "askSize": 1, "marketCap": 76594352, "fiftyTwoWeekLow": 0.774, "fiftyTwoWeekHigh": 1.8, "priceToSalesTrailing12Months": 9.943444, "fiftyDayAverage": 0.94952, "twoHundredDayAverage": 1.085545, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 99950200, "profitMargins": 0.0, "floatShares": 69972458, "sharesOutstanding": 75843504, "sharesShort": 767373, "sharesShortPriorMonth": 777769, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0101, "heldPercentInsiders": 0.07762, "heldPercentInstitutions": 0.20109, "shortRatio": 3.33, "shortPercentOfFloat": 0.0108, "impliedSharesOutstanding": 75843504, "bookValue": -0.465, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -31878000, "trailingEps": -0.45, "forwardEps": -0.5, "enterpriseToRevenue": 12.975, "enterpriseToEbitda": -4.083, "52WeekChange": -0.404908, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 1.0099, "targetHighPrice": 8.0, "targetLowPrice": 5.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationMean": 1.42857, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 23591000, "totalCashPerShare": 0.311, "ebitda": -24481000, "totalDebt": 49973000, "quickRatio": 4.359, "currentRatio": 4.49, "totalRevenue": 7703000, "revenuePerShare": 0.109, "returnOnAssets": -0.48458, "grossProfits": 7703000, "freeCashflow": -17203124, "operatingCashflow": -18949000, "revenueGrowth": 0.208, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -5.71676, "financialCurrency": "USD", "symbol": "CLSD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "REGULAR", "shortName": "Clearside Biomedical, Inc.", "longName": "Clearside Biomedical, Inc.", "regularMarketChangePercent": 4.1342807, "regularMarketPrice": 1.0099, "corporateActions": [], "regularMarketTime": 1742411939, "exchange": "NGM", "messageBoardId": "finmb_145617165", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "earningsTimestamp": 1743105600, "earningsTimestampStart": 1743105600, "earningsTimestampEnd": 1743105600, "earningsCallTimestampStart": 1743107400, "earningsCallTimestampEnd": 1743107400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.45, "epsForward": -0.5, "epsCurrentYear": -0.475, "priceEpsCurrentYear": -2.1261053, "fiftyDayAverageChange": 0.060379982, "fiftyDayAverageChangePercent": 0.063590005, "twoHundredDayAverageChange": -0.07564497, "regularMarketChange": 0.039899945, "regularMarketDayRange": "0.9655 - 1.045", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 239744, "fiftyTwoWeekLowChange": 0.23589998, "fiftyTwoWeekLowChangePercent": 0.30478033, "fiftyTwoWeekRange": "0.774 - 1.8", "fiftyTwoWeekHighChange": -0.7901, "fiftyTwoWeekHighChangePercent": -0.43894446, "fiftyTwoWeekChangePercent": -40.4908, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1464874200000, "twoHundredDayAverageChangePercent": -0.069683865, "priceToBook": -2.1718278, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Clearside Biomedical", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]